Cases 1 - 10 of 14
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB et al v. Alembic Pharmaceuticals Limited
as 1:2021cv00982
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 271
AbbVie Inc. et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2020cv01009
Plaintiff:
Genentech, Inc. and AbbVie Inc.
Defendant:
Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. and Alembic Global Holding SA
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Alembic Pharmaceuticals Limited et al
as 1:2020cv00202
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Cadilla Healthcare Ltd. and others
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 1
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2020cv00074
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and Alembic Pharmaceuticals Limited
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2019cv02021
Defendant:
Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Alembic Global Holding SA and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
CyDex Pharmaceuticals, Inc. v. Alembic Global Holding SA et al
as 1:2019cv00956
Defendant:
Alembic Global Holding SA, Alembic Pharmaceuticals, Ltd. and Alembic Pharmaceuticals, Inc.
Plaintiff:
CyDex Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. Alembic Pharmaceuticals, Ltd., et al
as 1:2019cv00177
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Alembic Pharmaceuticals, Ltd., Alembic Global Holding SA and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GmbH et al v. Alembic Pharmaceuticals Limited et al
as 1:2017cv00675
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Alembic Pharmaceuticals Ltd. et al
as 1:2016cv01316
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Alembic Pharmaceuticals Ltd. , Alembic Limited , Alembic Global Holding SA and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
